Total Payments
$666.07
2024 Payments
$100.68
Companies
12
Transactions
17
Medicare Patients
14,228
Medicare Billing
$2.2M
Payment Breakdown by Category
Food & Beverage$464.60 (69.8%)
Education$167.77 (25.2%)
Gifts$33.70 (5.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $464.60 | 10 | 69.8% |
| Education | $167.77 | 6 | 25.2% |
| Gift | $33.70 | 1 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $118.65 | 1 | $0 (2019) |
| Clovis Oncology, Inc. | $105.99 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $93.65 | 1 | $0 (2022) |
| Eisai Inc. | $76.02 | 1 | $0 (2024) |
| PFIZER INC. | $73.23 | 1 | $0 (2017) |
| Genentech USA, Inc. | $48.93 | 2 | $0 (2019) |
| Welch Allyn | $33.70 | 1 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $32.65 | 2 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $25.67 | 2 | $0 (2019) |
| Tempus AI, Inc | $24.66 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $100.68 | 2 | Eisai Inc. ($76.02) |
| 2023 | $21.00 | 1 | Mirati Therapeutics, Inc. ($21.00) |
| 2022 | $93.65 | 1 | Janssen Biotech, Inc. ($93.65) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $66.35 | 3 | Welch Allyn ($33.70) |
| 2019 | $262.18 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($118.65) |
| 2017 | $110.29 | 2 | PFIZER INC. ($73.23) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $76.02 | General |
| Category: Oncology | ||||||
| 05/01/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: NONE | ||||||
| 07/20/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 09/07/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $93.65 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 08/17/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $17.33 | General |
| Category: Oncology | ||||||
| 07/13/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $15.32 | General |
| Category: Oncology | ||||||
| 05/06/2020 | Welch Allyn | None (Device) | Gift | In-kind items and services | $33.70 | General |
| Category: Not Applicable | ||||||
| 10/24/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $7.20 | General |
| Category: Oncology | ||||||
| 05/23/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: Oncology | ||||||
| 05/07/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $95.00 | General |
| Category: Oncology | ||||||
| 04/25/2019 | Genentech USA, Inc. | Perjeta (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: BioOncology | ||||||
| 01/25/2019 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $118.65 | General |
| Category: Oncology | ||||||
| 12/07/2017 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $73.23 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2017 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $37.06 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 72 | 4,054 | 31,552 | $1.3M | $364,319 |
| 2022 | 59 | 3,180 | 28,016 | $1.1M | $371,136 |
| 2021 | 52 | 3,019 | 41,316 | $1.3M | $519,777 |
| 2020 | 76 | 3,975 | 68,819 | $2.6M | $969,824 |
Total Patients
14,228
Total Services
169,703
Medicare Billing
$2.2M
Procedure Codes
259
All Medicare Procedures & Services
259 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 12 | 2,800 | $269,000 | $119,740 | 44.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 252 | 444 | $122,980 | $43,238 | 35.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,620 | $87,720 | $29,667 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 242 | 286 | $47,192 | $17,969 | 38.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 80 | 127 | $55,864 | $13,545 | 24.2% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 21 | 486 | $52,488 | $10,386 | 19.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 405 | 1,199 | $23,421 | $10,005 | 42.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 370 | 936 | $35,367 | $9,651 | 27.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 394 | 1,271 | $73,429 | $9,645 | 13.1% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 40 | 53 | $32,966 | $8,667 | 26.3% |
| J3490 | Unclassified drugs | Office | 2023 | 12 | 23 | $29,815 | $7,279 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 49 | $22,269 | $6,893 | 31.0% |
| 85055 | Reticulated (young) platelet measurement | Office | 2023 | 44 | 141 | $10,857 | $4,939 | 45.5% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 15 | 22 | $17,064 | $4,643 | 27.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $16,560 | $4,036 | 24.4% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 21 | 2,860 | $22,880 | $3,878 | 16.9% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 53 | 72 | $33,984 | $3,681 | 10.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $9,885 | $3,504 | 35.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 22 | 57 | $11,894 | $3,400 | 28.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 38 | 57 | $20,892 | $3,072 | 14.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 141 | 222 | $17,538 | $2,918 | 16.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $10,695 | $2,566 | 24.0% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 28 | 95 | $10,890 | $2,376 | 21.8% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 49 | 230 | $8,046 | $2,096 | 26.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 29 | $5,100 | $1,894 | 37.1% |
About Dr. Aref Agheli, MD
Dr. Aref Agheli, MD is a Hematology & Oncology healthcare provider based in East Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1710204573.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aref Agheli, MD has received a total of $666.07 in payments from pharmaceutical and medical device companies, with $100.68 received in 2024. These payments were reported across 17 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($464.60).
As a Medicare-enrolled provider, Agheli has provided services to 14,228 Medicare beneficiaries, totaling 169,703 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 259 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location East Syracuse, NY
- Active Since 05/03/2010
- Last Updated 08/03/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1710204573
Products in Payments
- NINLARO (Drug) $118.65
- Rubraca (Drug) $105.99
- DARZALEX (Biological) $93.65
- Lenvima (Drug) $76.02
- IBRANCE (Drug) $73.23
- Perjeta (Biological) $48.93
- None (Device) $33.70
- OPDIVO (Biological) $32.65
- KEYTRUDA (Biological) $25.67
- XT CDX (Device) $24.66
- KRAZATI (Drug) $21.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in East Syracuse
Santosh Kumar, Md, MD
Hematology & Oncology — Payments: $31,857
Hematology & Oncology $31,857
Vinod Varki, M.d, M.D
Hematology & Oncology — Payments: $14,348
Hematology & Oncology $14,348
Dr. Tarek Sousou, Md, MD
Hematology & Oncology — Payments: $3,099
Hematology & Oncology $3,099
Santo Difino, M.d, M.D
Hematology & Oncology — Payments: $1,159
Hematology & Oncology $1,159
Benny Wong, M.d, M.D
Hematology & Oncology — Payments: $1,083
Hematology & Oncology $1,083
Richard Cherny, M.d, M.D
Hematology & Oncology — Payments: $530.53
Hematology & Oncology $530.53